In ERα-positive breast cancer, although most of the patients initially responded well to tamoxifen or other endocrine treatment, eventually many of them inevitably developed to drug-resistant and metastatic disease which is incurable8. This evidence concerns the gene ESR1 and metastatic neoplasm.